Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Aug 2009 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Invesco India Largecap Fund |
|---|---|
| 28 Aug 2009 | ₹100.00 |
| 27 Jan 2011 | ₹110.51 |
| 27 Jun 2012 | ₹101.49 |
| 25 Nov 2013 | ₹123.39 |
| 26 Apr 2015 | ₹164.92 |
| 24 Sep 2016 | ₹164.02 |
| 23 Feb 2018 | ₹172.45 |
| 24 Jul 2019 | ₹178.00 |
| 22 Dec 2020 | ₹209.42 |
| 23 May 2022 | ₹205.05 |
| 22 Oct 2023 | ₹252.63 |
| 21 Mar 2025 | ₹259.27 |
| 20 Aug 2026 | ₹269.28 |
| Metric | Invesco · Regular · IDCW NAV ₹27.17 Very High risk ★★☆☆☆ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| -5.89% | -5.49% | |
| +2.78% | +7.73% | |
| +2.38% | +6.21% | |
| +5.31% | +4.02% | |
| +6.01% | +5.54% | |
| +2.16% | — | |
| +7.05% | +6.92% | |
| +6.99% | +6.12% | |
| +6.47% | +3.99% | |
| Risk | ||
| 17.71% | 14.74% | |
| -0.21 | 0.02 | |
| -0.25 | 0.03 | |
| -36.93% | -48.01% | |
| Nifty 100 | — | |
| -6.85% | -1.74% | |
| 1.36 | 0.98 | |
| 99.7% | 93.8% | |
| 146.7% | 102.3% | |
| 2.19% | 2.38% | |
| ₹1,742Cr | ₹1,495Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 22% | 58% | |
| Hiten Jain · 2.7y | — | |
| 28 Aug 2009 | — | |
| 53 | — | |
| 42.3% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.